Stem Cell
Research Areas
Products Related to Stem Cell(471)
- GC16702CHIR-99021 (CT99021)CAS: 252917-06-9Purity: >99.00%
CHIR-99021 (CT99021) is a kind of highly selective inhibitor of GSK-3, the IC 50 values for GSK-3α and GSK-3β are 10nM and 6.7nM respectively.
- GC17107PluriSIn #1 (NSC 14613)CAS: 91396-88-2Purity: >99.50%
A selective inhibitor of stearoyl-CoA desaturase
- GC17671YO-01027 (Dibenzazepine, DBZ)CAS: 209984-56-5Purity: >98.00%
YO-01027 (Dibenzazepine, DBZ) is a γ-secretase inhibitor, with the IC 50 values of 2.64±0.30 and 2.92±0.22nM for APPL and Notch cleavage, respectively.
- GC17764BML-284 (Wnt agonist 1)CAS: 853220-52-7Purity: >99.50%
BML-284 (Wnt agonist 1) is a potent agonist of Wnt signaling, with an EC 50 value of 0.7μM for inducing β-catenin- and TCF-dependent transcriptional activity.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC16454 | IWP-2 | 686770-61-6 | >98.00% | |
IWP-2 is a specific inhibitor of Porcupine enzyme in the Wnt signaling pathway, with an IC50 value of 27 nM. | ||||
| GC16617 | IM-12 | 1129669-05-1 | >98.00% | |
GSK-3β inhibitor, potent | ||||
| GC16701 | SKI II | 312636-16-1 | >98.00% | |
Sphingosine kinase(SK) inhibitor | ||||
| GC16702 | CHIR-99021 (CT99021) | 252917-06-9 | >99.00% | |
CHIR-99021 (CT99021) is a kind of highly selective inhibitor of GSK-3, the IC 50 values for GSK-3α and GSK-3β are 10nM and 6.7nM respectively. | ||||
| GC16711 | PNU 74654 | 113906-27-7 | >99.00% | |
Wnt signaling pathway inhibitor | ||||
| GC16789 | GANT 58 | 64048-12-0 | >99.50% | |
An inhibitor of Gli transcription | ||||
| GC16893 | ICG 001 | 780757-88-2 | >98.00% | |
ICG 001 is an inhibitor of the β-catenin pathway. ICG 001 functions by specifically binding to CBP (IC 50 =3μM). | ||||
| GC16963 | HLY78 | 854847-61-3 | >98.00% | |
positive modulator of the Wnt/β-catenin pathway | ||||
| GC17042 | O4I2 | 165682-93-9 | >98.00% | |
Oct3/4 inducer | ||||
| GC17071 | IWP-3 | 687561-60-0 | >98% | |
inhibitor of Wnt production | ||||
| GC17107 | PluriSIn #1 (NSC 14613) | 91396-88-2 | >99.50% | |
A selective inhibitor of stearoyl-CoA desaturase | ||||
| GC17251 | QS 11 | 944328-88-5 | >99.00% | |
ARFGAP1 inhibitor,Wnt/beta-catenin pathway modulator | ||||
| GC17327 | OAC2 | 6019-39-2 | >98.00% | |
Oct4 activator | ||||
| GC17339 | ML-243 | 1426576-80-8 | >98% | |
inhibitor of cancer stem cells | ||||
| GC17468 | ML 239 | 1378872-36-6 | >99.50% | |
inhibitor of the breast cancer stem cells | ||||
| GC17534 | GSK343 | 1346704-33-3 | >98.00% | |
A selective, cell-permeable EZH2 inhibitor | ||||
| GC17535 | UM 191 | - | >98% | |
UM 191 | ||||
| GC17606 | CCT251545 | 1661839-45-7 | >99.50% | |
Orally bioavailable and potent WNT signaling inhibitor | ||||
| GC17607 | Pyrintegrin | 1228445-38-2 | >98% | |
enhances the survival of hESC | ||||
| GC17671 | YO-01027 (Dibenzazepine, DBZ) | 209984-56-5 | >98.00% | |
YO-01027 (Dibenzazepine, DBZ) is a γ-secretase inhibitor, with the IC 50 values of 2.64±0.30 and 2.92±0.22nM for APPL and Notch cleavage, respectively. | ||||
| GC17690 | Cromolyn sodium | 15826-37-6 | >99.00% | |
Mast cell membrane stabilizer | ||||
| GC17713 | Oxy-16 | 596-94-1 | >98% | |
Oxy-16 is an endogenous metabolic intermediate. | ||||
| GC17764 | BML-284 (Wnt agonist 1) | 853220-52-7 | >99.50% | |
BML-284 (Wnt agonist 1) is a potent agonist of Wnt signaling, with an EC 50 value of 0.7μM for inducing β-catenin- and TCF-dependent transcriptional activity. | ||||
| GC17782 | Cardionogen 1 | 577696-37-8 | >98% | |
Wnt signaling modulator | ||||
